Quick Answer
BELITE BIO, INC reported R&D Expense of $45.38 million for fiscal year 2025.
BELITE BIO, INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $45.38M | +51.6% |
| 2024 | $29.94M | +20.5% |
| 2023 | $24.84M | +180.1% |
| 2022 | $8.87M | +19.5% |
| 2021 | $7.42M | +101.2% |
| 2020 | $3.69M | — |
- BELITE BIO, INC showed an increase of +51.6% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, BELITE BIO, INC’s r&d expense has grown by 1130.4% (from $3.69 million to $45.38 million).
- The most recent figure is from BELITE BIO, INC’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: